ADORA2A and Alzheimer disease: As an example, the potential role of caffeinein preventing Alzheimer’s disease (AD), which is likely dueto the cerebroprotective effects of adenosine A2A receptor antagonism,43 has led to a Phase 3 clinical trial to testcaffeine’s efficacy to slow cognitive decline in early moderateAD (NCT04570085).